Department of Medicine

Harm Reduct J. 2026 Jun 17. doi: 10.1186/s12954-026-01486-y. Online ahead of print. ABSTRACT BACKGROUND: As xylazine-adulterated opioids become more prevalent in the U.S., people who use drugs (PWUD) face growing risks from sedation, withdrawal, and wounds. This study explores PWUD perceptions on recognizing xylazine exposure including its physical effects and clinical harms and how these […]

infectious-diseasemedicinepublic-health

J Am Pharm Assoc (2003). 2026 Jun 17:103469. doi: 10.1016/j.japh.2026.103469. Online ahead of print. ABSTRACT BACKGROUND: Patients with opioid use disorder encounter challenges obtaining buprenorphine (BUP) at pharmacies, increasing their risk of treatment non-adherence and illicit drug use. OBJECTIVES: The purpose of this quality improvement (QI) initiative was to implement and evaluate a multi-…

medicinepharmacologypublic-health

Kidney360. 2026 Jun 2. doi: 10.34067/KID.0000001198. Online ahead of print. ABSTRACT BACKGROUND: Legalization of cannabis across several US states may increase its use by individuals on hemodialysis, particularly among those with chronic pain. Contemporary data on frequency or factors associated with cannabis use by this population are limited. METHODS: We conducted a secondary analysis of […]

chronic-painmedicine

Led by William Bain, MD, and Jana Jacobs, PhD, researchers from the Divisions of Pulmonary, Allergy, Critical Care and Sleep Medicine and Infectious Diseases helped uncover how vascular injury may drive life-threatening complications in viral respiratory infections.

cardiologyinfectious-diseasemedicine

Research led by Anita Saraf, MD, PhD, identified key cellular and molecular changes driving liver disease in patients with Fontan circulation, offering new insights into diagnosis, transplant timing, and potential future therapies.

infectious-diseasemedicine

Hepatol Commun. 2026 May 22;10(6):e0955. doi: 10.1097/HC9.0000000000000955. eCollection 2026 Jun 1. ABSTRACT BACKGROUND: Chronic pain is common and uniquely challenging to manage in people with cirrhosis. The purpose of this pilot study was to evaluate the feasibility and acceptability of a tailored pain self-management (PSM) intervention for people with cirrhosis and chronic pain. METHODS: This …

medicinepain-management

JAMA Netw Open. 2026 May 1;9(5):e2611514. doi: 10.1001/jamanetworkopen.2026.11514. ABSTRACT IMPORTANCE: Due to the impact of high-potency synthetic opioids on medication for opioid use disorder (MOUD) initiation, hospital-based addiction clinicians adapted their practice to improve care, with decisions often guided by limited evidence. OBJECTIVE: To derive expert consensus on best practices for h…

addictionmedicinepublic-health
research.ioresearch.io

Sign up to keep scrolling

Create your feed subscriptions, save articles, keep scrolling.

Already have an account?